Isolation of contractile cardiomyocytes from human pluripotent stem-cell-derived cardiomyogenic cultures using a human NCX1-EGFP reporter

Stem Cells and Development

Volumn 24, Issue 1, 2015, Pages 11-20

  Ovchinnikov, Dmitry A ^a   Hidalgo, Alejandro ^a   Yang, Seung Kwon ^a   Zhang, Xinli ^a   Hudson, James ^a   Mazzone, Stuart B ^a   Chen, Chen ^a   Cooper White, Justin J ^a,b   Wolvetang, Ernst J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b CSIRO   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE MARKER; ENHANCED GREEN FLUORESCENT PROTEIN; NCX 1 ENHANCED GREEN FLUORESCENT PROTEIN; TROPONIN T; UNCLASSIFIED DRUG; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; SODIUM CALCIUM EXCHANGE PROTEIN; SODIUM-CALCIUM EXCHANGER 1;

ARTICLE; CELL CLONING; CELL DIFFERENTIATION; CELL MATURATION; DNA MODIFICATION; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; ENHANCER REGION; HEART DEVELOPMENT; HEART MUSCLE CELL; HUMAN; HUMAN CELL; MUSCLE FIBER CONTRACTION; PHENOTYPE; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; STROMA CELL; BIOSYNTHESIS; CELL LINE; CULTURE TECHNIQUE; CYTOLOGY; FLOW CYTOMETRY; GENETICS; HEART CONTRACTION; METABOLISM; REPORTER GENE;

CELL CULTURE TECHNIQUES; CELL LINE; FLOW CYTOMETRY; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; RECOMBINANT FUSION PROTEINS; SODIUM-CALCIUM EXCHANGER;

EID: 84919786193     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2014.0195     Document Type: Article

References (53)

1. Zhang J, M Klos, GF Wilson, AM Herman, X Lian, KK Raval, MR Barron, L Hou, AG Soerens, et al. (2012). Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: the matrix sandwich method. Circ Res 111:1125-1136.
2. Kattman SJ, AD Witty, M Gagliardi, NC Dubois, M Niapour, A Hotta, J Ellis and G Keller. (2010). Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 8:228-240.
3. Lian X, J Zhang, K Zhu, TJ Kamp and SP Palecek. (2013). Insulin inhibits cardiac mesoderm, not mesendoderm, formation during cardiac differentiation of human pluripotent stem cells and modulation of canonical Wnt signaling can rescue this inhibition. Stem Cells 31:447-457.
4. Hudson J, D Titmarsh, A Hidalgo, E Wolvetang and J Cooper-White. (2012). Primitive cardiac cells from human embryonic stem cells. Stem Cells Dev 21:1513-1523.
5. Burridge PW, S Thompson, MA Millrod, S Weinberg, X Yuan, A Peters, V Mahairaki, VE Koliatsos, L Tung and ET Zambidis. (2011). A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. Plos One 6: e18293.
6. Zhang J, M Klos, GF Wilson, AM Herman, X Lian, KK Raval, MR Barron, L Hou, AG Soerens, et al. (2012). Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: the matrix sandwich method. Cir Res 111:1125-1136.
7. Kim C, J Wong, J Wen, S Wang, C Wang, S Spiering, NG Kan, S Forcales, PL Puri, et al. (2013). Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs. Nature 494:105-110.
8. Lan F, AS Lee, P Liang, V Sanchez-Freire, PK Nguyen, L Wang, L Han, M Yen, Y Wang, et al. (2013). Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. Cell Stem Cell 12:101-113.
9. Novak A, L Barad, N Zeevi-Levin, R Shick, R Shtrichman, A Lorber, J Itskovitz-Eldor and O Binah. (2012). Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to Beta-adrenergic stimulation. J Cell Mol Med 16:468-482.
10. Egashira T, S Yuasa, T Suzuki, Y Aizawa, H Yamakawa, T Matsuhashi, Y Ohno, S Tohyama, S Okata, et al. (2012). Disease characterization using LQTS-specific induced pluripotent stem cells. Cardiovasc Res 95:419-429.
11. Mercola M, A Colas and E Willems. (2013). Induced Pluripotent Stem Cells in Cardiovascular Drug Discovery. Cir Res 112:534-548.
12. M Hoekstra, C Mummery, AM Wilde, C Bezzina and A Verkerk. (2012). Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias. Front Physiol 3:1-14.
13. Yang L, MH Soonpaa, ED Adler, TK Roepke, SJ Kattman, M Kennedy, E Henckaerts, K Bonham, GW Abbott, et al. (2008). Human cardiovascular progenitor cells develop from a KDR1 embryonic-stem-cell-derived population. Nature 453:524-528.
14. Laflamme MA, KY Chen, AV Naumova, V Muskheli, JA Fugate, SK Dupras, H Reinecke, C Xu, M Hassanipour, et al. (2007). Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 25:1015-1024.
15. Guo L, RMC Abrams, JE Babiarz, JD Cohen, S Kameoka, MJ Sanders, E Chiao and KL Kolaja. (2011). Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Sci 123:281-289.
16. Braam SR, L Tertoolen, A van de Stolpe, T Meyer, R Passier and CL Mummery. (2010). Prediction of druginduced cardiotoxicity using human embryonic stem cellderived cardiomyocytes. Stem Cell Res 4:107-116.
17. Liang P, F Lan, AS Lee, T Gong, V Sanchez-Freire, Y Wang, S Diecke, K Sallam, JW Knowles, et al. (2013). Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals diseasespecific patterns of cardiotoxicity. Circulation 127:1677-1691.
18. Yokoo N, S Baba, S Kaichi, A Niwa, T Mima, H Doi, S Yamanaka, T Nakahata and T Heike. (2009). The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells. Biochem Biophys Res Commun 387:482-488.
19. Ghafar-Zadeh, E JR Waldeisen and LP Lee. (2011). Engineered approaches to the stem cell microenvironment for cardiac tissue regeneration. Lab Chip 11:3031-3048.
20. Jurga M, N Forraz and CP McGuckin. (2010). Artificial human tissues from cord and cord blood stem cells for multi-organ regenerative medicine: viable alternatives to animal in vitro toxicology. Altern Lab Anim 38:183-192.
21. Kehat I, L Khimovich, O Caspi, A Gepstein, R Shofti, G Arbel, I Huber, J Satin, J Itskovitz-Eldor and L Gepstein. (2004). Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol 22:1282-1289.
22. Huang W, B Dai, Z Wen, RW Millard, XY Yu, K Luther, M Xu, TC Zhao, HT Yang, et al. (2013). Molecular strategy to reduce in vivo collagen barrier promotes entry of NCX1 positive inducible pluripotent stem cells (iPSC(NCX1 + )) into ischemic (or injured) myocardium. PLoS One 8:e70023.
23. Shiba Y, S Fernandes, WZ Zhu, D Filice, V Muskheli, J Kim, NJ Palpant, J Gantz, KW Moyes, et al. (2012). Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature 489:322-325.
24. Lian X, C Hsiao, G Wilson, K Zhu, LB Hazeltine, SM Azarin, KK Raval, J Zhang, TJ Kamp and SP Palecek. (2012). Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc Natl Acad Sci U S A 109: E1848-E1857.
25. Minami I, K Yamada, TG Otsuji, T Yamamoto, Y Shen, S Otsuka, S Kadota, N Morone, M Barve, et al. (2012). Small molecule that promotes cardiac differentiation of human pluripotent stem cells under defined, cytokine-and xenofree conditions. Cell Rep 2 1448-1460.
26. Mummery CL, Oostwaard DW, P Doevendans, R Spijker, S van den Brink, R Hassink, M van der Heyden, T Opthof, M Pera, et al. (2003). Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 107:2733-2740.
27. Mummery CL, J Zhang, ES Ng, DA Elliott, AG Elefanty and TJ Kamp. (2012). Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ Res 111:344-358.
28. Kakkar R and RT Lee. (2010). Intramyocardial fibroblast myocyte communication. Circ Res 106:47-57.
29. Fujiu K and R Nagai. (2014). Fibroblast-mediated pathways in cardiac hypertrophy. J Mol Cell Cardiol 70:64-73.
30. Sano M, K Fukuda, H Kodama, J Pan, M Saito, J Matsuzaki, T Takahashi, S Makino, T Kato and S Ogawa. (2000). Interleukin-6 family of cytokines mediate angiotensin IIinduced cardiac hypertrophy in rodent cardiomyocytes. J Biol Chem 275:29717-29723.
31. Dubois NC, AM Craft, P Sharma, DA Elliott, EG Stanley, AG Elefanty, A Gramolini and G Keller. (2011). SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells. Nat Biotechnol 29:1011-1018.
32. Spater D, MK Abramczuk, K Buac, L Zangi, MW Stachel, J Clarke, M Sahara, A Ludwig and KR Chien. (2013). A HCN4 + cardiomyogenic progenitor derived from the first heart field and human pluripotent stem cells. Nat Cell Biol 15:1098-1106.
33. Ritner C, Wong SSY, FW King, SS Mihardja,W Liszewski, DJ Erle, RJ Lee and HS Bernstein. (2011). An engineered cardiac reporter cell line identifies human embryonic stem cell-derived myocardial precursors. PLOS One 6:e16004.
34. Fu J-D, P Jiang, S Rushing, J Liu, N Chiamvimonvat and RA Li. (2010). Na +/Ca2 + exchanger is a determinant of excitation-contraction coupling in human embryonic stem cell-derived ventricular cardiomyocytes. Stem Cells Dev 19:773-782.
35. Barth AS, E Kizana, RR Smith, J Terrovitis, P Dong, MK Leppo, Y Zhang, J Miake, EN Olson, et al. (2008). Lentiviral vectors bearing the cardiac promoter of the Na +-Ca2 + exchanger report cardiogenic differentiation in stem cells. Mol Ther 16:957-964.
36. Elliott DA, SR Braam, K Koutsis, ES Ng, R Jenny, EL Lagerqvist, C Biben, T Hatzistavrou, CE Hirst, et al. (2011). NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes. Nat Methods 8:1037-1040.
37. Litwin SE, J Li and JHB Bridge. (1998). Na-Ca exchange and the trigger for sarcoplasmic reticulum Ca release: studies in adult rabbit ventricular myocytes. Biophys J 75:359-371.
38. Levesque PC, O Leblanc and J Hume. (2006). Role of reverse-mode Na +-Ca2+ exchange in excitation-contraction coupling in the heart. Abb N Y Acad Sci 639:386-397.
39. Briggs JA, J Sun, J Shepherd, DA Ovchinnikov, TL Chung, SP Nayler, LP Kao, CA Morrow, NY Thakar, et al. (2012). Integration-free induced pluripotent stem cells model genetic and neural developmental features of Down syndrome etiology. Stem Cells 31:467-478.
40. Ovchinnikov DA, JP Turner, DM Titmarsh, NY Thakar, DC Sin, JJ Cooper-White and EJ Wolvetang. (2012). Generation of a human embryonic stem cell line stably expressing high levels of the fluorescent protein mCherry. World J Stem Cells 4:71-79.
41. Lian X, J Zhang, SM Azarin, K Zhu, LB Hazeltine, X Bao, C Hsiao, TJ Kamp and SP Palecek. (2013). Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/beta-catenin signaling under fully defined conditions. Nat Protoc 8:162-175.
42. He JQ, Y Ma, Y Lee, JA Thomson and TJ Kamp. (2003). Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ Res 93:32-39.
43. Satin J, I Kehat, O Caspi, I Huber, G Arbel, I Itzhaki, J Magyar, EA Schroder, I Perlman and L Gepstein. (2004). Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes. J Physiol 559:479-496.
44. Qian L, Y Huang, CI Spencer, A Foley, V Vedantham, L Liu, SJ Conway, JD Fu and D Srivastava. (2012). In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 485:593-598.
45. Domian IJ, M Chiravuri, P van der Meer, AW Feinberg, X Shi, Y Shao, SM Wu, KK Parker and KR Chien. (2009). Generation of functional ventricular heart muscle from mouse ventricular progenitor cells. Science 326:426-429.
46. Ardehali R, SR Ali, MA Inlay, OJ Abilez, MQ Chen, TA Blauwkamp, M Yazawa, Y Gong, R Nusse, M Drukker and IL Weissman. (2013). Prospective isolation of human embryonic stem cell-derived cardiovascular progenitors that integrate into human fetal heart tissue. Proc Natl Acad Sci U S A 110:3405-3410.
47. Nicholas SB, W Yang, SL Lee, H Zhu, KD Philipson and J Lytton. (1998). Alternative promoters and cardiac muscle cell-specific expression of the Na +/Ca2 + exchanger gene. Am J Physiol 274:H217-H232.
48. Linck B, Z Qiu, Z He, Q Tong, DW Hilgemann and KD Philipson. (1998). Functional comparison of the three isoforms of the Na +/Ca2 + exchanger (NCX1, NCX2, NCX3). Am J Physiol 274:C415-C423.
49. Boyman L, H Mikhasenko, R Hiller and D Khananshvili. (2009). Kinetic and equilibrium properties of regulatory calcium sensors of NCX1 protein. J Biol Chem 284:6185-6193.
50. Koban MU, SA Brugh, DR Riordon, KA Dellow, HT Yang, D Tweedie and KR Boheler. (2001). A distant upstream region of the rat multipartite Na( + )-Ca(2 + ) exchanger NCX1 gene promoter is sufficient to confer cardiac-specific expression. Mech Dev 109:267-279.
51. Burridge PW, G Keller, JD Gold and JC Wu. (2011). Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell 10:16-28.
52. Camellitia P, TK Borgb and P Kohla. (2005). Structural and functional characterisation of cardiac fibroblasts. Cardiovasc Res 65:40-51.
53. Christoforou N, RA Miller, CM Hill, CC Jie, AS McCallion and JD Gearhart. (2008). Mouse ES cell-derived cardiac precursor cells are multipotent and facilitate identification of novel cardiac genes. J Clin Invest 118:894-903.